Filed
by the Registrant x
|
|
Check
the appropriate box:
|
|
o
|
Preliminary
Proxy Statement
|
o
|
Confidential, for
use of the Commission only (as permitted by Rule
14a-6(e)(2))
|
x
|
Definitive
Proxy Statement
|
o
|
Definitive
Additional Materials
|
o
|
Soliciting
Material Pursuant to
§240.14a-12
|
PACIFICHEALTH
LABORATORIES, INC.
|
(Name
of Registrant as Specified In Its
Charter)
|
Payment
of Filing Fee (Check the appropriate box):
|
||
x
|
No
fee required.
|
|
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
1)
|
Title
of each class of securities to which transaction
applies:
|
|
2)
|
Aggregate
number of securities to which transaction applies:
|
|
3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):
|
|
4)
|
Proposed
maximum aggregate value of transaction:
|
|
5)
|
Total
fee paid:
|
|
o
|
Fee
paid previously with preliminary materials.
|
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
|
|
1)
|
Amount
Previously Paid:
|
|
2)
|
Form,
Schedule or Registration Statement No.:
|
|
3)
|
Filing
Party:
|
|
4)
|
Date
Filed:
|
1.
|
To
elect six (6) directors;
|
2.
|
To
approve the Company’s 2010 Incentive Stock Option Plan, in the form
attached as Exhibit A to the Proxy Statement;
|
3.
|
To
ratify the appointment of Weiser LLP as our independent auditors for the
fiscal year ending December 31, 2009; and
|
4.
|
To
transact such other business as may properly come before the meeting or
any adjournment or adjournments
thereof.
|
By
order of the Board of Directors,
|
|
/s/
Stephen P. Kuchen
|
|
Stephen
P. Kuchen, Secretary
|
|
May
11, 2009
|
Name
and Address (1)
|
Common
Stock (2)
Amount
Beneficially Owned
|
Common
Stock (2)
Percentage
of Class
|
||||||
5% Beneficial Owners
|
||||||||
None
|
||||||||
Officers and Directors
|
||||||||
Jason
Ash (3)
|
508,000
|
3.4
|
%
|
|||||
President,
Chief Executive Officer, and
|
||||||||
Director
|
||||||||
Stephen
P. Kuchen (4)
|
274,030
|
1.8
|
%
|
|||||
Vice
President –Finance,
|
||||||||
Chief
Financial Officer,
|
||||||||
Treasurer,
and Secretary
|
||||||||
Robert
Portman (5)
|
3,365,425
|
21.5
|
%
|
|||||
Chairman
of the Board and a Director
|
||||||||
David
I. Portman (6)
|
624,012
|
4.2
|
%
|
|||||
Director
|
||||||||
Michael
Cahr (7)
|
424,560
|
2.9
|
%
|
|||||
Director
|
||||||||
Adam
Mizel (8)
|
624,840
|
4.3
|
%
|
|||||
Director
|
Marc
Particelli (9)
|
256,114
|
1.7
|
%
|
|||||
Director
|
||||||||
Executive
Officers and
|
6,076,981
|
37.2
|
%
|
|||||
Directors,
as a group (7 persons)
|
*
|
Less
than one percent
|
(1)
|
Except
as otherwise indicated, the address of each person named in the above
table is c/o PacificHealth Laboratories, Inc., 100 Matawan Road, Suite
420, Matawan, NJ 07747-3913.
|
(2)
|
Common
Stock which is issuable upon the exercise of a stock option which is
presently exercisable or which becomes exercisable within sixty days is
considered outstanding for the purpose of computing the percentage
ownership (x) of persons holding such options, and (y) of officers and
directors as a group with respect to all options held by officers and
directors.
|
(3)
|
Includes
150,000 shares issuable upon the exercise of options granted pursuant to
individual incentive agreements and not covered under any stockholder
approved equity incentive plan (“NON-ISO”).
|
(4)
|
Includes
133,334 shares issuable upon the exercise of options granted under our
1995 Incentive Stock Plan (the “1995 Plan”) and 120,000 shares issuable
upon the exercise of options granted pursuant to individual incentive
agreements and not covered under any stockholder approved equity incentive
plan (“NON-ISO”).
|
(5)
|
Includes
1,025,000 shares issuable upon the exercise of options granted pursuant to
individual incentive agreements and not covered under any stockholder
approved equity incentive plan (“NON-ISO”). Does not include 200,000
shares of Common Stock owned by Jennifer Portman, Dr. Portman’s wife,
individually and as Trustee for his and her children, as to which Dr.
Portman disclaims beneficial ownership.
|
(6)
|
Includes
70,000 shares issuable upon the exercise of options granted under our 1995
Plan and 35,000 shares issuable upon the exercise of options granted under
our 2000 Incentive Stock Option Plan (the “2000 Plan”).
|
(7)
|
Includes
40,000 shares issuable upon the exercise of options granted under our 1995
Plan and 20,000 shares issuable upon the exercise of options granted under
our 2000 Plan.
|
(8)
|
Includes
447,780 shares that are owned by Aquifer Opportunity Fund, L.P., of which
Mr. Mizel is the Managing Principal of the General Partner. Mr. Mizel
disclaims beneficial ownership of the shares owned by Aquifer Opportunity
Fund, L.P., except to the extent of his pecuniary interest therein. Also
includes 40,000 shares issuable to Mr. Mizel upon the exercise of options
granted under our 2000 Plan.
|
(9)
|
Includes
40,000 shares issuable upon the exercise of options granted under our 2000
Plan.
|
●
|
the
name, age, business address and residence address of the
candidate;
|
||
●
|
the
principal occupation or employment of the candidate;
|
||
●
|
the
class and number of our shares which are beneficially owned by the
candidate;
|
||
●
|
any
other information relating to the candidate that is required to be
disclosed under the SEC’s proxy rules (including without limitation such
person’s written consent to being named in any proxy statement as a
nominee and to serving as a director if elected);
|
||
●
|
the
name and address, as they appear on our books, of the stockholder making
the proposal; and
|
||
●
|
the
class and number of our shares which are beneficially owned by the
stockholder making the
proposal.
|
Name
|
Position
with the Company
|
||
Jason
Ash
|
President
and Chief Executive Officer
|
||
Stephen
P. Kuchen
|
Vice
President-Finance, Chief Financial Officer, Secretary, and
Treasurer
|
Name
and Principal
Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
Option
Awards ($)
|
Non-
Equity
Incentive
Plan
Compen-
sation
($)
|
Nonqualified
Deferred
Compensa-
tion Earnings
($)
|
All
Other
Compensa-
tion ($)
|
Total
($)
|
||||||||||||||||||
(a)
|
(b)
|
(c)
|
(d) | (e) | (f) | (g) |
(h)
|
(i) | (j) | ||||||||||||||||||
Jason
Ash,
President,
Chief
Executive
Officer and
a
Director
|
2008
|
$
|
295,000
|
(1)
|
—
|
—
|
$
|
79,352
|
(2)
|
—
|
—
|
$
|
55,000
|
(1)
|
$
|
429,352
|
|||||||||||
Robert
Portman,
Chairman
of the
Board,
Chief
Executive
Officer,
President
and Chief
Scientific
Officer
|
2008
|
$
|
172,083
|
(3)
|
—
|
—
|
$
|
216,883
|
(2)(3)
|
—
|
—
|
$
|
129,740
|
(4)
|
$
|
518,706
|
|||||||||||
2007
|
$
|
295,000
|
—
|
—
|
$
|
134,484
|
(2)
|
—
|
—
|
$
|
11,700
|
(5)
|
$
|
441,184
|
|||||||||||||
Stephen
P. Kuchen,
Chief
Financial
Officer,
Treasurer,
and
Secretary
|
2008
|
$
|
154,500
|
—
|
—
|
$
|
32,439
|
(2)
|
—
|
—
|
$
|
0
|
(6)
|
$
|
186,939
|
||||||||||||
2007
|
$
|
150,000
|
$
|
4,000
|
—
|
$
|
43,528
|
(2)
|
—
|
—
|
$
|
0
|
(6)
|
$
|
197,528
|
||||||||||||
Executive
Officer
|
Number
of Shares of Common
Stock
Underlying Options
|
Exercise
Price
|
Grant
Date
|
||||
Stephen
Kuchen
|
50,000
|
$ |
0.23
|
September
17,
2008
|
Option
Awards
|
Stock
Awards
|
||||||||||||||||||||||
Name
|
Number
of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
|
Number
of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
|
Equity
Incentive
Plan
Awards:
Number
of
Securities
Underlying
Unexercised
Unearned
Options
(#)
|
Option
Exercise
Price
($)
|
Option
Expiration
Date
|
Number
of
Shares
or
Units
of
Stock
That
Have
Not
Vested
(#)
|
Market
Value
of
Shares
or
Units
of
Stock
That
Have
Not
Vested
($)
|
Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units
or
Other Rights
That
Have Not
Vested
(#)
|
Equity
Incentive
Plan
Awards:
Market
or
Payout
Value
of
Unearned
Shares,
Units
or
Other Rights
That
Have Not
Vested
($)
|
||||||||||||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
(i)
|
(j)
|
||||||||||||||
Jason
Ash, President, Chief Executive Officer and a Director
|
—
|
600,000
|
(1)
|
—
|
$
|
0.65
|
01/13/2013
|
—
|
—
|
—
|
—
|
||||||||||||
Stephen
P. Kuchen, Chief Financial
|
—
|
50,000
|
(2)
|
—
|
$
|
0.23
|
09/17/2013
|
—
|
—
|
—
|
—
|
||||||||||||
Officer,
Treasurer, and Secretary
|
33,333
|
(3)
|
16,667
|
(3)
|
—
|
$
|
1.13
|
12/13/2011
|
|||||||||||||||
66,666
|
(4)
|
33,334
|
(4)
|
—
|
$
|
0.60
|
02/13/2011
|
||||||||||||||||
120,000
|
(5)
|
—
|
—
|
$
|
0.70
|
10/01/2009
|
Name
|
Fees
Earned
or
Paid
in
Cash
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive
Plan
Compensation
($)
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other
Compensation
($)
|
Total
($)
|
||||||||||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
(h)
|
||||||||||||
David
I. Portman
|
—
|
$
|
19,100
|
$
|
28,425
|
(1)
|
—
|
—
|
—
|
$
|
47,525
|
||||||||
Michael
Cahr
|
—
|
$
|
19,100
|
$
|
28,425
|
(1)
|
—
|
—
|
—
|
$
|
47,525
|
||||||||
|
|||||||||||||||||||
Adam
Mizel
|
—
|
$
|
19,100
|
$
|
18,980
|
(1)
|
—
|
—
|
—
|
$
|
38,080
|
||||||||
Marc
Particelli
|
—
|
$
|
19,100
|
$
|
18,980
|
(1)
|
—
|
—
|
—
|
$
|
38,080
|
||||||||
Robert
Portman
|
—
|
$
|
12,500
|
—
|
—
|
—
|
—
|
$
|
12,500
|
●
|
The
Statement of Changes in Beneficial Ownership of Securities on Form 4 filed
by Robert Portman was filed late. This Form 4 disclosed the acquisition by
Dr. Portman of shares of our common stock at market prices on June 25,
2008, June 27, 2008, July 7, 2008 and July 11,
2008.
|
Reason
for termination of employment or service
|
Option
expires on date below, but in any event no later
than the date of expiration of the Option term |
|
Termination
by the Company without Cause (as defined in the Plan) or termination by
the grantee after at least 90 days advance written notice
|
90
days after the date on which the grantee ceases to be employed by or
provide service to the Company
|
|
Termination
because grantee is Disabled (as defined in Plan)
|
One
year after the date on which the grantee ceases to be employed by or
provide service to the Company
|
|
Termination
because grantee dies while employed by or providing service to the
Company, or within 90 days after the date on which the grantee ceases to
be employed by or provide service as a result of a termination by the
Company without Cause, or if the grantee provides the Company with at
least 90 days advance written notice of termination of
employment
|
One
year after the date on which the grantee ceases to be employed by or
provide service to the Company
|
Fee
Category
|
|
Fiscal
2008
|
Fiscal
2007
|
||||||
Audit
Fees¹
|
$ | 95,875 | $ | 90,463 | |||||
Audit-Related
Fees2
|
$ | - 0 - | $ | - 0 - | |||||
Tax
Fees3
|
$ | 3,300 | $ | 10,105 | |||||
All
Other Fees4
|
$ | - 0 - | $ | 5,000 | |||||
TOTAL
|
$ | 99,575 | $ | 105,568 |
/s/
Stephen P. Kuchen
|
|
Stephen
P. Kuchen, Secretary
|
1.
|
ELECTION OF
DIRECTORS.
|
o
|
FOR all nominees
listed
|
o
|
WITHHOLD AUTHORITY to
vote
|
||
below
(except as marked to
|
for
all nominees listed below
|
||||
the
contrary below)
|
INSTRUCTIONS:
TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE, STRIKE A LINE
THROUGH THE
|
|
NOMINEE’S
NAME IN THE LIST BELOW:
|
|
Jason
Ash, Robert Portman, David Portman, Michael Cahr, Adam Mizel, Marc
Particelli
|
2.
|
PROPOSAL
TO APPROVE THE 2010 INCENTIVE STOCK OPTION PLAN.
|
|||
o FOR
|
o AGAINST
|
o ABSTAIN
|
||
3.
|
PROPOSAL
TO RATIFY THE APPOINTMENT OF WEISER LLP AS THE INDEPENDENT PUBLIC
ACCOUNTANTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31,
2009.
|
|||
o FOR
|
o AGAINST
|
o ABSTAIN
|
Date
|
|||
Signature
|
|||
Signature,
if held
jointly
|